Journals / Güncel Retina Dergisi / 2018 / Cilt: 2 - Sayı: 1

Screening and Follow-up for Retinopathy of Prematurity

Prematüre Retinopatisi’nde Tarama ve Takip

Pages
29–33
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The aim of this study is to review the most current global screening programs and the latest situation in our country

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Retinopathy of prematurity (ROP) that occurs in premature babies and can result in blindness is one of the vascular diseases of retina.
📊
Key Findings & Data:Currently, increased preterm birth and the survival of very small babies cause an increase in ROP incidence.
💡
Conclusion & Impact:The aim of this study is to review the most current global screening programs and the latest situation in our country
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Retinopathy of prematurity (ROP) that occurs in premature babies and can result in blindness is one of the vascular diseases of retina. Currently, increased preterm birth and the survival of very small babies cause an increase in ROP incidence. Through effective screening programs, ROP can be detected and treated timely. The aim of this study is to review the most current global screening programs and the latest situation in our country

Özet

Prematüre retinopatisi (PR), erken doğan bebeklerde görülen ve körlükle sonuçlanabilen retinanın vasküler hastalıklarından bir tanesidir. Günümüzde artan erken doğumlar ve çok küçük bebeklerin bile yaşatılabilmesi PR insidansında bir artışa sebep olmaktadır. Etkin tarama programları sayesinde PR zamanında tespit edilip tedavi edilebilmektedir. Bu derlemenin amacı en güncel küresel tarama programlarını ve ülkemizdeki son durumu gözden geçirmektir

🔖

Cite This Article

ALYAMAÇ, E. S. (2018). Screening and Follow-up for Retinopathy of Prematurity. Güncel Retina Dergisi, Cilt: 2 - Sayı: 1, 29–33. https://ajindex.com/articles/224247

References (1)

  1. Gilbert C, Muhit M. Twenty years of childhood blindness: what have we learnt? Community eye health / International Centre for Eye Health. 2008;21(67):46-7. 2.Hartnett ME. Pathophysiology and Mechanisms of Severe Retinopathy of Prematurity. Ophthalmology. 2015;122(1):200-210. 3. Sorsby A. The Incidences and Causes of Blindness in England and Wales, 1948-1962. HM Stationery Office, 1966. 4. Gilbert C, Rahi J, Eckstein M, O’Sullivan J, Foster A. Retinopathy of prematurity in middle-income countries. Lancet. 1997;350(9070):12-4. 5.Askin DF, Diehl-Jones W. Retinopathy of prematurity. Crit Care Nurs Clin North Am. 2009;21(2):213-33. 6. Blencowe H, Lawn JE, Vazquez T, Fielder A, Gilbert C. Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. Pediatr res. 2013;74 (1):35-49. 7. Mora JS, Waite C, Gilbert CE, Breidenstein B, Sloper JJ. A worldwide survey of retinopathy of prematurity screening. Br J Ophthalmol. 2017.doi: 10.1136/bjophthalmol-2017-310709.[Epub ahead of print]. 8.Türkiye Prematüre Retinopatisi Rehberi - 2016. 9. Raju TN, Higgins RD, Stark AR, Leveno KJ. Optimizing care and outcome for late-preterm (near- term) bebeks: a summary of the workshop sponsored by the National Institute of Child Health and Human Development. Pediatrics 2006;118(3):1207-14. 10. Schaffer DB, Palmer EA, Plotsky DF, Metz HS, Flynn JT, Tung B et al. Prognostic factors in the natural course of retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmol. 1993;100(2):230-73. 11. AMERICAN ACADEMY OF PEDIATRICS SECTION ON OPHTHALMOLOGY, et al. Screening examination of premature infants for retinopathy of prematurity. Pediatrics, 2013, 131(1): 189-195. 12.Wilkinson AR, Haines L, Head K, Fielder AR. UK retinopathy of prematurity guideline. Early Hum Dev. 2008;84(2):71-4. 13.AkmanI, DemirelU, YeniceÖ,I İlerisoyH, KazokoğluH, ÖzekE. Screening criteria for retinopathy of prematurity in developing countries. Eur J Ophthalmol. 2010;20(5):931-7. 14.Başmak H, Niyaz L, Sahin A, Erol N, Gürsoy HH. Retinopathy of prematurity: screening guidelines need to be reevaluated for developing countries. Eur J Ophthalmol. 2009;20(4):752-5. 15.Bas AY, Koc E, Dilmen U and ROP Neonatal Study Group. Incidence and severity of retinopathy of prematurity in Turkey. Br J Ophthalmol. 2015;99(10);1311-4. 16. Fleck BW, McIntosh N. Pathogenesis of retinopathy of pre- maturity and possible preventive strategies.